San Francisco Bay Area Biometrics Consulting
Request a Consultation Pharma Recruiting  Contact Us Iphone  925-320-7600 
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7
San Francisco Bay Area Biometrics Consulting
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZlcnNpb249IjEuMCIgd2lkdGg9IjkwMCIgaGVpZ2h0PSIzMDAiID48L3N2Zz4=

CDISC Upgrades Standard for Clinical Trial Registries (CTR)

B2ap3 Large Cdisc101

The new standard from the Clinical Data Interchange Standards Consortium (CDISC) will help industry generate submissions for multiple, global clinical trial registries, particularly those from the World Health Organization (WHO), European Medicines Agency (EMA) and ClinicalTrials.gov from a single file.

The standard, known as the Clinical Trial Registry (CTR) XML, is inspired by the International Committee of Medical Journal Editors (ICMJE), and is based upon the 20-item WHO Trial Registration Data Set as well as EudraCT specific extensions.

“The CTR standard maximizes the re-use of existing CDISC transport standards by extending the Operational Data Model (ODM-XML) and including Study/Trial Design Model (SDM-XML) content,” CDISC said in a statement. “This makes the standard a more general solution that any trial registry could potentially use as the means to populate their registry with structured content from a clinical trial sponsor’s systems.”

CTR-XML will help companies harmonize messages to international registries, and technology vendors will be able to support a "write once, use many times" tool based on a single XML file, CDISC said. The standard is based upon the common elements mapped between the registries, which are based upon the 20-item WHO Trial Registration Data Set.

“This standard will save the industry a lot of time in registering trials with multiple registries and is an essential step toward creating registries that house consistent, high-quality data, which will make them more useful to patients seeking research trials,” said Paul Houston, head of the CDISC Europe Foundation. “The next stage will extend the standard, creating an underlying structured protocol standard, results summaries and Identification of Medicinal Products (IDMP) compliance (an ISO standard), to further increase the richness, reliability and traceability of registry information.”

CDISC is looking for volunteers and sponsors to join the CTR team and those interested can email for details.

MS Clinical Trial Database is now Available to All...

Related Posts

Ready to Get Started?

Schedule a No Obligation Consultation with a Clindata Insight Representative Today

Admin
28 April 2017
We are looking forward to attending PharmaSUG2017 in Baltimore, MD.  Will you join us? PharmaSU...
Admin
14 February 2017
Please join us at the DahShu 2017 Data Science and Computational Precision Health. The theme for thi...
Richelle Serrano
23 May 2016
Over the last five years, the CSS has grown from its infant years, passed through adolescence and ma...

Copyright © 2016   Clindata Insight Inc.   All Rights Reserved

Clindata Insight Inc, provides equal employment opportunities (EEO) to all applicants for employment without regard to race, color, religion, sex, national orgin, age, disability or genetics.  In addition to federal law requirements Clindata Insight complies with applicable state and local laws governing non discrimination in employment.

        (925) 320-7600